(Q28282622)

4

Christopher J L Murray

0 references

Majid Ezzati

5

Majid Ezzati

0 references

Alan D. Lopez

Alan D Lopez

3

1 reference

ORCID Public Data File 2021

Goodarz Danaei

1

Goodarz Danaei

0 references

Stephen Vander Hoorn

2

Stephen Vander Hoorn

0 references

language of work or name

English

0 references

publication date

19 November 2005

0 references

published in

The Lancet

0 references

volume

366

0 references

page(s)

1784-93

0 references

issue

9499

0 references

cites work

Cancer statistics, 2003.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967725-2

7 January 2021

Trends in prostate cancer mortality among black men and white men in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967725-2

7 January 2021

Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967725-2

7 January 2021

Periodic screening for breast cancer: the HIP Randomized Controlled Trial. Health Insurance Plan

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967725-2

7 January 2021

Are we winning the fight against cancer? An epidemiological assessment. EACR--Mühlbock memorial lecture

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967725-2

7 January 2021

Tobacco habits and risk of lung, oropharyngeal and oral cavity cancer: a population-based case-control study in Bhopal, India.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967725-2

7 January 2021

Emerging tobacco hazards in China: 1. Retrospective proportional mortality study of one million deaths

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967725-2

7 January 2021

Proportion of breast cancer cases in the United States explained by well-established risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967725-2

7 January 2021

Population attributable risk for breast cancer: diet, nutrition, and physical exercise

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967725-2

7 January 2021

Population attributable risks of esophageal and gastric cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967725-2

7 January 2021

The Causes of Cancer: Quantitative Estimates of Avoidable Risks of Cancer in the United States Today

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967725-2

7 January 2021

Cancer burden in the year 2000. The global picture

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967725-2

7 January 2021

Selected major risk factors and global and regional burden of disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967725-2

7 January 2021

Global and regional estimates of cancer mortality and incidence by site: I. Application of regional cancer survival model to estimate cancer mortality distribution by site

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967725-2

7 January 2021

Global and regional estimates of cancer mortality and incidence by site: II. Results for the global burden of disease 2000

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967725-2

7 January 2021

Estimates of global and regional potential health gains from reducing multiple major risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967725-2

7 January 2021

Trends in mortality from cervical cancer in the Nordic countries: association with organised screening programmes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967725-2

7 January 2021

International incidence rates of invasive cervical cancer after introduction of cytological screening.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967725-2

7 January 2021

Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967725-2

7 January 2021

Randomised controlled trial of faecal-occult-blood screening for colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967725-2

7 January 2021

Randomised study of screening for colorectal cancer with faecal-occult-blood test

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967725-2

7 January 2021

EUSOMA review of mammography screening

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967725-2

7 January 2021

On the efficacy of screening for breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967725-2

7 January 2021

Hereditary nonpolyposis colorectal cancer: preventive management

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967725-2

7 January 2021

Screening for lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967725-2

7 January 2021

Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967725-2

7 January 2021

Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967725-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967725-2

1 reference

7 January 2021

10.1016/S0140-6736(05)67725-2

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

2003304

2003304

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference